Treatment-Emergent Hypophosphatemia Following Administration of Intravenous Iron

EP: 1.Introduction and Overview of the Physiological Role of Iron Metabolism

EP: 2.Defining Iron Deficiency

EP: 3.Common Causes of Iron Deficiency

EP: 4.Confirming Iron Deficiency Diagnosis

EP: 5.The Clinical Role of Intravenous Iron

EP: 6.Unmet Need for Addressing the Use of IV Iron

EP: 7.Real-World Applications of Intravenous Iron

EP: 8.Overview of Iron Formulations

EP: 9.Generic Formulations of Iron

EP: 10.Dose Timing with Intravenous Iron

EP: 11.Safety of Intravenous Iron

EP: 12.Infusion Reactions to Intravenous Iron

EP: 13.How to Manage Infusion Reactions with Intravenous Iron

EP: 14.Practical Tools for the Administration of Intravenous Iron

Now Viewing

EP: 15.Treatment-Emergent Hypophosphatemia Following Administration of Intravenous Iron

EP: 16.Collaboration and Communication Across the Healthcare Team

Video content above is prompted by the following:

• Treatment-emergent hypophosphatemia is now widely recognized as a phenomenon that can occur following administration of certain IV iron formulations and within the first 2 weeks after administration. Can you discuss the mechanism of treatment-emergent hypophosphatemia?